Einloggen
E-Mail
Passwort
Passwort anzeigen
Merken
Passwort vergessen?
Watchlisten für Ihre Werte
Registrieren
Registrieren
Mitglied werden
Kostenlos registrieren
Abonnent werden
Unser Angebot
Einstellungen
Einstellungen
Dynamische Kurse 
OFFON
  1. Startseite
  2. Aktien
  3. Deutschland
  4. Xetra
  5. VITA 34 AG
  6. News
  7. Andere Sprachen
    V3V   DE000A0BL849   A0BL84

VITA 34 AG

(V3V)
  Bericht
ÜbersichtKurseChartsNewsRatingsTermineUnternehmenFinanzenAnalystenschätzungenRevisionenDerivate 
ÜbersichtAlle NewsAndere SprachenPressemitteilungenOffizielle PublikationenBranchen-News
Nachrichten in anderen Sprachen über VITA 34 AG
2021Vita 34 presents itself in new size for the first time at the Annual General Meeting 20..
2021Vita 34 again increases sales and margins in the third quarter
2021VITA 34 AG Reports Earnings Results for the Third Quarter and Nine Months Ended Septemb..
2021Vita 34 AG Announces Withdrawal of Guidance for Financial Year 2021
2021VITA 34 : extends the acceptance period under PBKM exchange offer
2021VITA 34 : Commences Offer Period for Polski Bank Komorek Takeover
2021VITA 34 : launches voluntary public exchange offer for PBKM shares
2021VITA 34 : again achieves double-digit growth in revenues and earnings in the first half of..
2021VITA 34 AG Affirms Earnings Guidance for the Full Fiscal Year 2021
2021VITA 34 AG Reports Earnings Results for the Second Quarter Ended June 30, 2021
2021VITA 34 : Names New CFO
2021VITA 34 AG : Andreas Schafhirt appointed as new Chief Financial Officer of Vita 34 AG
2021VITA 34 AG Announces Chief Financial Officer Changes
2021VITA 34 : publishes figures for the first quarter of 2021
2021VITA 34 AG Provides Earnings Guidance for the Year 2021
2021VITA 34 : Polski Bank Komorek Agree To Merge Via Share Swap
2021VITA 34 : signs Business Combination Agreement with Polski Bank Komórek Macierzystych S.A.
2021VITA 34 AG : Vita 34 AG and Warsaw-listed Polski Bank Komórek Macierzystych S.A. sign busi..
2021VITA 34 AG entered into a Business Combination Agreement to acquire Polski Bank Komórek..
2021VITA 34 AG : Preliminary announcement of the publication of quarterly reports and quarterl..
2021VITA 34 : continues to grow in 2020 in core markets after good year-end business
2021VITA 34 AG Provides Earnings Guidance for the Year 2021
2020VITA 34 AG Reports Earnings Results for the Third Quarter Ended September 30, 2020
2020VITA 34 : manages crisis environment well with a strong third quarter
2020VITA 34 AG Provides Revenue Guidance for the Full Year 2020
2020VITA 34 AG : Preliminary announcement of the publication of quarterly reports and quarterl..
2020Vita 34 Ag Reports Earnings Results for the Second Quarter Ended June 30, 2020
2020VITA 34 : Business development of Vita 34 gains significant momentum again in the second q..
2020VITA 34 AG Confirms Financial Guidance for the Full Year 2020
2020DGAP-WPÜG : Attainment of Control / Target company: VITA 34 AG; Bidder: AOC Health GmbH
2020AOC Health GmbH acquired a 27.3% stake in VITA 34 AG.
2020VITA 34 AG Reports Earnings Results for the First Quarter Ended March 31, 2020
2020VITA 34 : Business development of Vita 34 stable and unaffected by COVID-19 development so..
2020VITA 34 AG : Preliminary announcement of the publication of quarterly reports and quarterl..
2020VITA 34 AG : Proposed resolution to the Annual General Meeting on the suspension of the di..
2020VITA 34 AG Propose to Suspend the Dividend for the Financial Year 2019
2020Vita 34 Ag Reports Earnings Results for the Full Year Ended December 31, 2019
2020VITA 34 : successfully concludes also fourth quarter 2019 with organic growth
2020VITA 34 : concludes 2019 with significant earnings growth
2019Vita 34 Ag Reports Earnings Results for the Third Quarter Ended September 30, 2019
2019VITA 34 : Sales growth in core markets further increases margins for Vita 34
2019VITA 34 AG : Preliminary announcement of the publication of quarterly reports and quarterl..
2019Vita 34 Ag Reports Earnings Results for the Second Quarter Ended June 30, 2019
2019VITA 34 INTERNATIONAL : closes first half-year 2019 with operating profit margins at recor..
2019VITA 34 INTERNATIONAL : closes first half-year 2019 with operating profit margins at recor..
2019VITA 34 INTERNATIONAL : Annual General Meeting of Vita 34 AG agrees in all agenda items wi..
2019VITA 34 INTERNATIONAL : Annual General Meeting of Vita 34 AG agrees in all agenda items wi..
2019VITA 34 INTERNATIONAL : significantly increases profitability in the first quarter and pav..
2019VITA 34 AG Announces Earnings Results for the First Quarter of 2019
2019VITA 34 AG : Preliminary announcement of the publication of quarterly reports and quarterl..
2019VITA 34 INTERNATIONAL : surpasses full-year guidance for 2018 at earnings level
2019VITA 34 INTERNATIONAL : surpasses full-year guidance for 2018 at earnings level
2019VITA 34 AG Announces Earnings Results for the Year 2018; Provides Earnings Guidance for..
2019VITA 34 INTERNATIONAL : concludes 2018 with significant earnings growth according to preli..
2019VITA 34 AG Announces Preliminary Unaudited Earnings Results for the Year 2018
2019VITA 34 INTERNATIONAL : develops cell preparations as the source material for immune cell ..
2019Vita 34 AG Expands Business Activities and Broaden Scope by Setting Up New Business Are..
2018VITA 34 INTERNATIONAL : records increasing number of uses of umbilical cord blood
2018VITA 34 INTERNATIONAL : records increasing number of uses of umbilical cord blood
2018VITA 34 INTERNATIONAL : quadruples earnings with a clear increase in margins
2018VITA 34 INTERNATIONAL : quadruples earnings with a clear increase in margins
2018VITA 34 AG Reports Earnings Results for the First Nine Months of 2018
2018VITA 34 AG : Preliminary announcement of the publication of quarterly reports and quarterl..
2018VITA 34 AG : Half-year figures characterized by increasing momentum in core market Germany
2018VITA 34 AG : Half-year figures characterized by increasing momentum in core market Germany
2018Vita 34 AG Reports Earnings Results for the Six Months of 2018
2018VITA 34 AG : Notification and public disclosure of transactions by persons
2018VITA 34 INTERNATIONAL : refocuses R&D activities and implements cost reduction program in ..
2018VITA 34 INTERNATIONAL : refocuses R&D activities and implements cost reduction program in ..
2018VITA 34 AG : Notification and public disclosure of transactions by persons
2018VITA 34 INTERNATIONAL : introduces entry-level pricing model ‘VitaPur' and implement..
2018Vita 34 Introduces Entry-Level Pricing Model Vitapur
2018VITA 34 INTERNATIONAL : introduces entry-level pricing model 'VitaPur' and implements firs..
2018VITA 34 INTERNATIONAL : Stem cells from Germany for Australian boy
2018VITA 34 INTERNATIONAL : achieves further growth in market share and margin in the first qu..
1  2  3Weiter